Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Harvard Scientific files IND for impotency treatment

May 3, 1996

Progenitor delves into leptin receptor research

May 3, 1996

Redux cleared for marketing in U.S.

May 3, 1996

KY-455: Kyoto Pharm.'s ACAT/lipid peroxidation inhibitor

May 3, 1996

Ligand, Pfizer settle lawsuit related to osteoporosis drugs

May 3, 1996

Teijin reports vitamin D3 derivatives for osteoporosis

May 3, 1996

V-411 approved for marketing in China

April 26, 1996

Pulmonary insulin enters phase II

April 26, 1996

OT-5226: New antidiabetic from Otsuka

April 26, 1996

Amgen presents NESP

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...